ABSTRACT This real-world case examines how Mattel Inc., once the world’s largest toy company, manipulated earnings by improperly reclassifying Thomas A23; M40; M41.
Gujarathi et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: